James increased the price target for INmune Bio Inc. (NASDAQ: NASDAQ:INMB) shares to $23 from the previous $18, while maintaining an Outperform rating. According to InvestingPro data, the stock ...

Inflation data, Powell testimony, a 10-year auction and potentially new tariffs will keep Wall Street on alert Wednesday.

SignatureFD wants to stay independent yet be competitive with investor-backed firms writing big checks, its CEO says.

From security to development, the wealth management firm uses the Dynatrace platform to give senior executives information on ...

Stock analysts at Raymond James lowered their FY2025 EPS estimates for shares of Canaccord Genuity Group in a report issued ...

Equities researchers at Raymond James issued their Q3 2025 earnings per share (EPS) estimates for shares of Uranium Royalty in a report issued on Wednesday, February 5th. Raymond James analyst B.

Well-off retirees stand to gain thousands of dollars in tax savings every year if President Donald Trump succeeds in his bid to exempt Social Security benefits from income taxes, while younger workers ...

The next CEO of Raymond James talks about how private equity ownership has made for some difficult marriages in wealth ...

The Bank of N.T. Butterfield & Son Limited (NYSE:NTB) Q4 2024Management ViewCEO Michael Collins highlighted strong financial ...